Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001088860 | SCV000373177 | uncertain significance | Cutis laxa, autosomal recessive, type 1B | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV001088860 | SCV000652073 | likely benign | Cutis laxa, autosomal recessive, type 1B | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000788132 | SCV000927142 | uncertain significance | not provided | 2017-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000788132 | SCV001793193 | likely benign | not provided | 2020-10-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001088860 | SCV002049404 | uncertain significance | Cutis laxa, autosomal recessive, type 1B | 2020-10-25 | criteria provided, single submitter | clinical testing | The EFEMP2 c.934A>G; p.Thr312Ala variant (rs148410446), to our knowledge, is not reported in the medical literature or gene specific databases. This variant is found in the general population with an overall allele frequency of 0.07 % (198 /282,392 alleles) in the Genome Aggregation Database. The threonine at codon 312 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.38). Due to limited information, the clinical significance of the p.Thr312Ala variant is uncertain at this time. |
Ambry Genetics | RCV002446555 | SCV002682315 | benign | Cardiovascular phenotype | 2019-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003485576 | SCV004240555 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-17 | criteria provided, single submitter | clinical testing |